Isomorphic Labs Secures $600 Million Funding for AI-Powered Drug Discovery
Isomorphic Labs, a subsidiary of Google led by Demis Hassabis, CEO of Google DeepMind and Nobel Laureate, has successfully raised $600 million in funding from various investors, including Thrive Capital, a prominent backer of OpenAI. Focused on utilizing artificial intelligence for drug discovery, Isomorphic Labs leverages cutting-edge technology such as AlphaFold, a tool developed by […]
Continue Reading